Showing results (321-330 of 354) with videos related to

Sort By:
Pageof 36
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2011
Increased incidence and mortality associated with skin cancers after cardiac transplantM Alam, R N Brown, D H Silber, et al.
Endocrinology|October 30, 1998
Modulation of Mdm2 expression and p53-induced apoptosis in immortalized human ovarian granulosa cellsK Hosokawa, D Aharoni, A Dantes, et al.
Emergency Medicine Journal : EMJ|October 9, 2015
Effect of teleradiology upon pattern of transfer of head injured patients from a rural general hospital to a neurosurgical referral centre: follow-up studyI Ashkenazi, A R Zeina, B Kessel, et al.
Molecular and Cellular Biology|April 17, 1999
MDM2 suppresses p73 function without promoting p73 degradationX Zeng, L Chen, C A Jost, et al.
The British Journal of Radiology|July 11, 1998
An economic evaluation of the use of rare earth screens to reduce the radiation dose from diagnostic X-ray procedures in IsraelG M Ginsberg, T Schlesinger, A Ben-Shlomo, et al.
Nature|August 29, 1996
Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damageN Tanaka, M Ishihara, M S Lamphier, et al.
Cell Death and Differentiation|August 13, 2013
ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescenceF Fausti, S Di Agostino, M Cioce, et al.
The Journal of Biological Chemistry|July 8, 2000
Physical and functional interaction between p53 mutants and different isoforms of p73S Strano, E Munarriz, M Rossi, et al.
Cell Death and Differentiation|August 22, 2009
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYCN R Christoffersen, R Shalgi, L B Frankel, et al.
The Journal of Experimental Medicine|December 8, 1998
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugsM Müller, S Wilder, D Bannasch, et al.
Pageof 36